Physician

Monica Verma, MD

According to 2025 Medicare claims, Monica Verma, MD (NPI: 1518948124) practices hematology/oncology in the Dalton, GA market, with the plurality of this provider's patient population coming from Whitfield, GA. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 30720-8394.

Verma's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 455 traditional Medicare patients, billed 204,374 HCPCS/CPT codes, and received $2,174,824 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,466 prescription claims across 206 beneficiaries totaling $4,555,502 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 13 claims. Open Payments data shows 32 records totaling $744. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $434,061 to $4,555,502. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	566	126,134	$1,313,680
2016	534	141,131	$1,225,471
2017	526	179,535	$1,094,495
2018	552	308,452	$1,171,954
2019	516	329,332	$1,159,045
2020	487	203,250	$1,285,223
2021	477	265,189	$1,309,933
2022	427	226,449	$1,169,504
2023	464	156,030	$1,534,542
2024	455	204,374	$2,174,824

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	195	1,113	$434,061
2016	198	1,157	$767,712
2017	178	1,139	$1,167,504
2018	193	1,179	$1,509,683
2019	173	1,282	$2,751,502
2020	188	1,361	$3,012,848
2021	197	1,435	$3,099,268
2022	189	1,364	$3,782,971
2023	197	1,388	$4,340,125
2024	206	1,466	$4,555,502

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	25	172	$15,790
2016	N/R	70	$11,289
2017	N/R	11	$1,319
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	13	$1,745
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	13	$2,101

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	226	630	$139
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	247	440	$89
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	192	320	$13
36415	Insertion of needle into vein for collection of blood sample	351	2,256	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	357	2,425	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	79	2,248	$1,117,695
Revlimid	Lenalidomide	46	1,249	$774,186
Pomalyst	Pomalidomide	24	672	$516,278
Verzenio	Abemaciclib	27	756	$414,337
Vonjo	Pacritinib Citrate	11	330	$273,122

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	13	$2,101

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$744	Aveo Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Monica Verma, MD?

Tedicare shows public-source Medicare data for Monica Verma, MD (NPI 1518948124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Monica Verma, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Monica Verma, MD?

Monica Verma, MD is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Monica Verma, MD have Open Payments data?

Monica Verma, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.